Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version)

• Ishida Hideyuki

  Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitma Medical University

• Yamaguchi Tatsuro

  Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

• Tanakaya Kohji

  Department of Surgery, Iwakuni Clinical Center

• Akagi Kiwamu

  Department of Cancer Prevention and Molecular Genetics, Saitama Prefectural Cancer Center

• Inoue Yasuhiro

  Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine

• Kumamoto Kensuke

  Department of Coloproctology, Aizu Medical Center, Fukushima Medical University

• Shimodaira Hideki

  Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University

• Sekine Shigeki

  Division of Pathology and Clinical Laboratories, National Cancer Center, Hospital

• Tanaka Toshiaki

  Department of Surgical Oncology, The Graduate School of Medicine, The University of Tokyo

• Chino Akiko

  Division of Gastroenterology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research

• Tomita Naohiro

  Department of Surgery, Hyogo College of Medicine

• Nakajima Takeshi

  Endoscopy Division/Department of Genetic Medicine and Service, National Cancer Center Hospital

• Hasegawa Hirotoshi

  Department of Surgery, Keio University School of Medicine

• Hinoi Takao

  Department of Surgery, Institute for Clinical Research, National Hospital Organization Kure Medical Center and Chugoku Cancer Center

• Hirasawa Akira

  Department of Obstetrics and Gynecology, Keio University School of Medicine

• Miyakura Yasuyuki

  Department of Surgery Saitama Medical Center, Jichi Medical University

• Murakami Yoshie

  Department of Oncology Nursing, Faculty of Nursing, Toho University

• Muro Kei

  Department of Clinical Oncology, Aichi Cancer Center Hospital

• Ajioka Yoichi

  Division of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences, Niigata University

• Hashiguchi Yojiro

  Department of Surgery, Teikyo University

• Ito Yoshinori

  Department of Radiation Oncology, National Cancer Center Hospital

• Saito Yutaka

  Endoscopy Division, National Cancer Center Hospital

• Hamaguchi Tetsuya

  Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital

• Ishiguro Megumi

  Department of Translational Oncology, Tokyo Medical and Dental University Graduate School

• Ishihara Soichiro

  Department of Surgical Oncology, The Graduate School of Medicine, The University of Tokyo

• Kanemitsu Yukihide

  Colorectal Surgery Division, National Cancer Center Hospital

• Kawano Hiroshi

  Department of Gastroenterology, St. Mary's Hospital

• Kinugasa Yusuke

  Department of Colon and Rectal Surgery, Shizuoka Cancer Center

• Kokudo Norihiro

  Hepato‐Pancreato‐Biliary Surgery Division, Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, University of Tokyo

• Murofushi Keiko

  Radiation Oncology Department, The Cancer Institute Hospital, Japanese Foundation for Cancer Research

• Nakajima Takako

  Department of Clinical Oncology, St. Marianna University School of Medicine

• Oka Shiro

  Gastroenterology and Metabolism, Hiroshima University Hospital

• Sakai Yoshiharu

  Department of Surgery, Kyoto University

• Tsuji Akihiko

  Department of Clinical Oncology, Faculty of Medicine, Kagawa University

• Uehara Keisuke

  Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine

• Ueno Hideki

  Department of Surgery, National Defense Medical College

• Yamazaki Kentaro

  Division of Gastrointestinal Oncology, Shizuoka Cancer Center

• Yoshida Masahiro

  Department of Hemodialysis and Surgery, Chemotherapy Research Institute, International University of Health and Welfare

• Yoshino Takayuki

  Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East

• Boku Narikazu

  Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital

• Fujimori Takahiro

  Diagnostic Pathology Center, Shinko Hospital

• Itabashi Michio

  Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University

• Koinuma Nobuo

  Department of Health Administration and Policy, Tohoku Medical and Pharmaceutical University

• Morita Takayuki

  Department of Surgery, Cancer Center, Aomori Prefectural Central Hospital

• Nishimura Genichi

  Department of Surgery, Japanese Red Cross Kanazawa Hospital

• Sakata Yuh

  CEO, Misawa City Hospital

• Shimada Yasuhiro

  Division of Clinical Oncology, Kochi Health Sciences Center

• Takahashi Keiichi

  Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

• Tanaka Shinji

  Department of Endoscopy, Hiroshima University Hospital

• Tsuruta Osamu

  Division of GI Endoscopy, Kurume University School of Medicine

• Yamaguchi Toshiharu

  Department of Gastroenterological Surgery, The Cancer Institute Hospital, Japanese Foundation for Cancer Research

• Sugihara Kenichi

  Koujinkai Daiichi Hospital

• Watanabe Toshiaki

  Department of Surgical Oncology, The Graduate School of Medicine, The University of Tokyo

• Japanese Society for Cancer of the Colon and Rectum

Abstract

Hereditary colorectal cancer accounts for less than 5% of all colorectal cancer cases. Some of the unique characteristics that are commonly encountered in cases of hereditary colorectal cancer include early age at onset, synchronous/metachronous occurrence of the cancer, and association with multiple cancers in other organs, necessitating different management from sporadic colorectal cancer. While the diagnosis of familial adenomatous polyposis might be easy because usually 100 or more adenomas that develop in the colonic mucosa are in this condition, Lynch syndrome, which is the most commonly associated disease with hereditary colorectal cancer, is often missed in daily medical practice because of its relatively poorly defined clinical characteristics. In addition, the disease concept and diagnostic criteria for Lynch syndrome, which was once called hereditary non‐polyposis colorectal cancer, have changed over time with continual research, thereby possibly creating confusion in clinical practice. Under these circumstances, the JSCCR Guideline Committee has developed the “JSCCR Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (HCRC)," to allow delivery of appropriate medical care in daily practice to patients with familial adenomatous polyposis, Lynch syndrome, or other related diseases. The JSCCR Guidelines 2016 for HCRC were prepared by consensus reached among members of the JSCCR Guideline Committee, based on a careful review of the evidence retrieved from literature searches, and considering the medical health insurance system and actual clinical practice settings in Japan. Herein, we present the English version of the JSCCR Guidelines 2016 for HCRC.

Journal

• Journal of the Anus, Rectum and Colon

  Journal of the Anus, Rectum and Colon 2 (Suppl.I), S1-S51, 2018

  The Japan Society of Coloproctology

Keywords

• hereditary colorectal cancer
• guideline
• familial adenomatous polyposis
• Lynch syndrome

Details

• CRID: 1390001288034920320
• NII Article ID: 130006745103
• DOI: 10.23922/jarc.2017-028
• ISSN: 24323853
• Web Site: https://www.jstage.jst.go.jp/article/jarc/2/Suppl.I/2_2017-028/_pdf
• Text Lang: en
• Data Source:
  • JaLC
  • Crossref
  • CiNii Articles
  • KAKEN
• Abstract License Flag: Disallowed